These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 25151968)
41. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter]. Kong BH; Song Y; Ma DX; Qu X; Jiang S Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323 [TBL] [Abstract][Full Text] [Related]
42. Dictamnine promotes apoptosis and inhibits epithelial-mesenchymal transition, migration, invasion and proliferation by downregulating the HIF-1α and Slug signaling pathways. Wang JY; Wang Z; Li MY; Zhang Z; Mi C; Zuo HX; Xing Y; Wu YL; Lian LH; Xu GH; Piao LX; Ma J; Jin X Chem Biol Interact; 2018 Dec; 296():134-144. PubMed ID: 30266538 [TBL] [Abstract][Full Text] [Related]
43. Ikaros inhibits proliferation and, through upregulation of Slug, increases metastatic ability of ovarian serous adenocarcinoma cells. He LC; Gao FH; Xu HZ; Zhao S; Ma CM; Li J; Zhang S; Wu YL Oncol Rep; 2012 Oct; 28(4):1399-405. PubMed ID: 22859015 [TBL] [Abstract][Full Text] [Related]
44. Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition. Yagi H; Yotsumoto F; Miyamoto S Mol Cancer Ther; 2008 Oct; 7(10):3441-51. PubMed ID: 18852147 [TBL] [Abstract][Full Text] [Related]
45. MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α. Yeh YM; Chuang CM; Chao KC; Wang LH Int J Cancer; 2013 Aug; 133(4):867-78. PubMed ID: 23389731 [TBL] [Abstract][Full Text] [Related]
46. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway. Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291 [TBL] [Abstract][Full Text] [Related]
47. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines]. Song Y; Kong BH; Liu PS; Ma DX; Jiang S Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708 [TBL] [Abstract][Full Text] [Related]
48. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription. Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312 [TBL] [Abstract][Full Text] [Related]
49. HER2 mediates epidermal growth factor-induced down-regulation of E-cadherin in human ovarian cancer cells. Cheng JC; Qiu X; Chang HM; Leung PC Biochem Biophys Res Commun; 2013 Apr; 434(1):81-6. PubMed ID: 23542467 [TBL] [Abstract][Full Text] [Related]
50. Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment. Jiang H; Lin X; Liu Y; Gong W; Ma X; Yu Y; Xie Y; Sun X; Feng Y; Janzen V; Chen T Mol Med; 2012 Oct; 18(1):1197-208. PubMed ID: 22801793 [TBL] [Abstract][Full Text] [Related]
51. SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling. Gao H; Teng C; Huang W; Peng J; Wang C Int J Mol Sci; 2015 Sep; 16(9):21643-57. PubMed ID: 26370982 [TBL] [Abstract][Full Text] [Related]
52. Ling Zhi-8 reduces lung cancer mobility and metastasis through disruption of focal adhesion and induction of MDM2-mediated Slug degradation. Lin TY; Hsu HY Cancer Lett; 2016 Jun; 375(2):340-348. PubMed ID: 26992741 [TBL] [Abstract][Full Text] [Related]
53. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells. Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056 [TBL] [Abstract][Full Text] [Related]
54. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476 [TBL] [Abstract][Full Text] [Related]
55. SPOCK1 promotes the invasion and metastasis of gastric cancer through Slug-induced epithelial-mesenchymal transition. Chen D; Zhou H; Liu G; Zhao Y; Cao G; Liu Q J Cell Mol Med; 2018 Feb; 22(2):797-807. PubMed ID: 28940639 [TBL] [Abstract][Full Text] [Related]
56. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells. Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Yamada T; Kudo M; Yue J; Sakuragi N J Exp Clin Cancer Res; 2016 Sep; 35(1):132. PubMed ID: 27596137 [TBL] [Abstract][Full Text] [Related]
57. Emodin Inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer Cells via ILK/GSK-3 Lu J; Xu Y; Wei X; Zhao Z; Xue J; Liu P Biomed Res Int; 2016; 2016():6253280. PubMed ID: 28097141 [TBL] [Abstract][Full Text] [Related]
58. Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells. Cheng JC; Chang HM; Leung PC Oncogene; 2013 Feb; 32(8):1041-9. PubMed ID: 22508482 [TBL] [Abstract][Full Text] [Related]
59. Bisphenol A and nonylphenol have the potential to stimulate the migration of ovarian cancer cells by inducing epithelial-mesenchymal transition via an estrogen receptor dependent pathway. Kim YS; Hwang KA; Hyun SH; Nam KH; Lee CK; Choi KC Chem Res Toxicol; 2015 Apr; 28(4):662-71. PubMed ID: 25690688 [TBL] [Abstract][Full Text] [Related]
60. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C. Chang TH; Tsai MF; Gow CH; Wu SG; Liu YN; Chang YL; Yu SL; Tsai HC; Lin SW; Chen YW; Kuo PY; Yang PC; Shih JY Cancer Lett; 2017 Aug; 402():190-202. PubMed ID: 28610956 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]